Emerging immunotherapies in multiple myeloma
Year: 2020
Type: review
Source: BMJ
DOI: 10.1136/bmj.m3176
Authors: Urvi A Shah, Sham Mailankody
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: multiple myeloma, immunotherapy, allogeneic stem cell transplantation, immunomodulators, thalidomide, lenalidomide, pomalidomide, daratumumab, elotuzumab, chimeric antigen receptor T cells, bispecific antibodies, antibody-drug conjugates, immune checkpoint inhibitors, BCMA, plasma cells, mechanism of action, clinical trials
Open Access status: closed
Funder: National Cancer Institute
Award: Cancer Center Support Grant
OpenAlex ID: W3087716880
